Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer

BACKGROUND: Primary cytoreduction followed by platinum based chemotherapy is the primary treatment for advanced ovarian cancer. However neoadjuvant chemotherapy followed by interval debulking is an alternative option, particularly in those who may be poor surgical candidates. OBJECTIVE: The objectiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Obstet Gynecol
Main Authors: CHAM, Stephanie, CHEN, Ling, ST. CLAIR, Caryn M., HOU, June Y., TERGAS, Ana I., MELAMED, Alexander, ANANTH, Cande V., NEUGUT, Alfred I., HERSHMAN, Dawn L., WRIGHT, Jason D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545148/
https://ncbi.nlm.nih.gov/pubmed/30771346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2019.02.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados